Clinical Research Consulting

Milford, Connecticut 06460

0 studies enrolling now · 26 studies all time

What they study most

COVID-19, COVID-19 (Coronavirus Disease 2019), Dyspareunia, Healthy Participants, Hypertension, Stage I, Influenza, Influenza, Human, Influenza,Human, Lower Respiratory Tract Illness, Menopause, Musculoskeletal Pain, Obesity

Studies at this site

• A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
• A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years — Completed
• A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals — Completed
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People — Completed
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
• A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals — Completed
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — Completed
• A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People — Completed
• A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). — Completed
• Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age — Completed
• A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants — Completed
• A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure — Completed
• AMZ001 for the Treatment of Knee Osteoarthritis Symptoms — Completed
• A Clinical Trial of KT07 Capsule in the U.S.A — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea — Stopped early
• Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee — Completed
• Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women — Completed
• Long Duration Therapeutic Ultrasound on Tendon Injuries — Stopped early
• Study of Meloxicam Capsules to Treat Osteoarthritis Pain — Completed